Doctors have begun noticing a trend: they all seem to get full before finishing dinner, and it's likely thanks to drugs like ...
Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...
President Trump’s proposed tariffs on Denmark could have costly consequences for Americans relying on GLP-1 medications like ...
As Ozempic use rises, some patients report unexpected nasal symptoms, prompting researchers to investigate this new and unusual side effect.
A gut microbe has been identified that mimics the effects of Ozempic to mitigate diabetes and obesity. Here's how to take advantage of it.
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results